TARGET_MEDICAL_SOLUTIONS_ - Accounts


Company Registration No. 08339516 (England and Wales)
TARGET MEDICAL SOLUTIONS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019
PAGES FOR FILING WITH REGISTRAR
TARGET MEDICAL SOLUTIONS LTD
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
TARGET MEDICAL SOLUTIONS LTD
BALANCE SHEET
AS AT
31 MARCH 2019
31 March 2019
- 1 -
2019
2018
Notes
£
£
£
£
Fixed assets
Tangible assets
3
75,771
96,098
Current assets
Debtors
4
1,343,380
1,529,340
Cash at bank and in hand
89,871
-
1,433,251
1,529,340
Creditors: amounts falling due within one year
5
(1,337,586)
(1,681,954)
Net current assets/(liabilities)
95,665
(152,614)
Total assets less current liabilities
171,436
(56,516)
Provisions for liabilities
(11,975)
-
Net assets/(liabilities)
159,461
(56,516)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
159,361
(56,616)
Total equity
159,461
(56,516)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

TARGET MEDICAL SOLUTIONS LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MARCH 2019
31 March 2019
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 19 December 2019 and are signed on its behalf by:
Mr R F Smith
Director
Company Registration No. 08339516
TARGET MEDICAL SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2019
- 3 -
1
Accounting policies
Company information

Target Medical Solutions Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Equinox House, Staveley Road, Stanley Industrial Estate, Skelmersdale, Lancashire, WN8 8DZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

 

1.2
Turnover

Revenue represents amounts chargeable to clients for professional services inclusive of direct expenses incurred on client assignments but excluding value added tax. Revenue is recognised when a right to consideration has been obtained through performance under each contract,

 

Revenue is not recognised where the right to receive payment is contingent on events outside of the control of the company.

 

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold Land and Buildings
- 33% Straight Line
Fixtures, fittings & equipment
- 25% Reducing Balance
Computer equipment
- 25% Reducing Balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

TARGET MEDICAL SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
1
Accounting policies
(Continued)
- 4 -
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Recoverable amount is the higher of fair value less costs to sell and value in use. If the recoverable amount of an asset is estimated to be less than its carrying amount, the carrying amount of the asset is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

1.5
Cash at bank and in hand

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors are recognised at the settlement amount.

Basic financial liabilities

Basic financial liabilities, including creditors, are recognised at their settlement amount after allowing for any trade discounts due.

 

Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payables are classified as current liabilities if payment is due within one year or less.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

TARGET MEDICAL SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
1
Accounting policies
(Continued)
- 5 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10
Leases

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 30 (2018 - 30).

TARGET MEDICAL SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 6 -
3
Tangible fixed assets
Leasehold Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2018
51,792
80,359
132,151
Additions
-
9,985
9,985
At 31 March 2019
51,792
90,344
142,136
Depreciation and impairment
At 1 April 2018
3,596
32,457
36,053
Depreciation charged in the year
17,265
13,047
30,312
At 31 March 2019
20,861
45,504
66,365
Carrying amount
At 31 March 2019
30,931
44,840
75,771
At 31 March 2018
48,196
47,902
96,098
4
Debtors
2019
2018
Amounts falling due within one year:
£
£
Trade debtors
1,258,604
1,434,893
Other debtors
84,776
94,447
1,343,380
1,529,340
5
Creditors: amounts falling due within one year
2019
2018
£
£
Bank loans and overdrafts
-
1,516
Trade creditors
480,098
462,145
Taxation and social security
816,576
733,668
Other creditors
40,912
484,625
1,337,586
1,681,954

 

TARGET MEDICAL SOLUTIONS LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2019
- 7 -
6
Security

Barclays Bank PLC has a charge over monies deposited with the bank in respect of any loans owed by the company to the bank. At the year end there were no such loans.

7
Operating lease commitments

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2019
2018
£
£
86,240
77,320
2019-03-312018-04-01false19 December 2019CCH SoftwareCCH Accounts Production 2019.301No description of principal activityMr R F SmithMr D A ReesMr D J ByrneMrs L Woodward2019-12-19083395162018-04-012019-03-31083395162019-03-31083395162018-03-3108339516core:LandBuildings2019-03-3108339516core:OtherPropertyPlantEquipment2019-03-3108339516core:LandBuildings2018-03-3108339516core:OtherPropertyPlantEquipment2018-03-3108339516core:CurrentFinancialInstrumentscore:WithinOneYear2019-03-3108339516core:CurrentFinancialInstrumentscore:WithinOneYear2018-03-3108339516core:CurrentFinancialInstruments2019-03-3108339516core:CurrentFinancialInstruments2018-03-3108339516core:ShareCapital2019-03-3108339516core:ShareCapital2018-03-3108339516core:RetainedEarningsAccumulatedLosses2019-03-3108339516core:RetainedEarningsAccumulatedLosses2018-03-3108339516bus:Director12018-04-012019-03-3108339516core:LandBuildingscore:LeasedAssetsHeldAsLessee2018-04-012019-03-3108339516core:FurnitureFittings2018-04-012019-03-3108339516core:ComputerEquipment2018-04-012019-03-3108339516core:LandBuildings2018-03-3108339516core:OtherPropertyPlantEquipment2018-03-31083395162018-03-3108339516core:OtherPropertyPlantEquipment2018-04-012019-03-3108339516core:LandBuildings2018-04-012019-03-3108339516core:WithinOneYear2019-03-3108339516core:WithinOneYear2018-03-3108339516bus:PrivateLimitedCompanyLtd2018-04-012019-03-3108339516bus:SmallCompaniesRegimeForAccounts2018-04-012019-03-3108339516bus:FRS1022018-04-012019-03-3108339516bus:AuditExemptWithAccountantsReport2018-04-012019-03-3108339516bus:Director22018-04-012019-03-3108339516bus:Director32018-04-012019-03-3108339516bus:CompanySecretary12018-04-012019-03-3108339516bus:FullAccounts2018-04-012019-03-31xbrli:purexbrli:sharesiso4217:GBP